title: Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death.
abstract: Epstein-Barr virus (EBV) not only induces growth transformation in human B lymphocytes, but has more recently been shown to enhance B cell survival under suboptimal conditions where growth is inhibited; both effects are mediated through the coordinate action of eight virus-coded latent proteins. The effect upon cell survival is best recognized in EBV-positive Burkitt's lymphoma cell lines where activation of full virus latent gene expression protects the cells from programmed cell death (apoptosis). Here we show by DNA transfection into human B cells that protection from apoptosis is conferred through expression of a single EBV latent protein, the latent membrane protein LMP 1. Furthermore, we demonstrate that LMP 1 mediates this effect by up-regulating expression of the cellular oncogene bcl-2. The interplay between EBV infection and expression of this cellular oncogene has important implications for virus persistence and for the pathogenesis of virus-associated malignant disease.
authors.affiliation: Department of Cancer Studies University of Birmingham, England.
authors.forename: S
authors.initials: S
authors.lastname: Henderson
authors.forename: M
authors.initials: M
authors.lastname: Rowe
authors.forename: C
authors.initials: C
authors.lastname: Gregory
authors.forename: D
authors.initials: D
authors.lastname: Croom-Carter
authors.forename: F
authors.initials: F
authors.lastname: Wang
authors.forename: R
authors.initials: R
authors.lastname: Longnecker
authors.forename: E
authors.initials: E
authors.lastname: Kieff
authors.forename: A
authors.initials: A
authors.lastname: Rickinson
mesh_terms: D000956:Antigens, Viral / Q000502:physiology*; D001402:B-Lymphocytes / Q000166:cytology*; D002460:Cell Line; D002470:Cell Survival; D004249:DNA Damage; D005786:Gene Expression Regulation; D015967:Gene Expression Regulation, Viral; D004854:Herpesvirus 4, Human / Q000502:physiology*; D006801:Humans; D066298:In Vitro Techniques; D011518:Proto-Oncogene Proteins / Q000502:physiology*; D019253:Proto-Oncogene Proteins c-bcl-2; D014162:Transfection; D014763:Viral Matrix Proteins
chemical_list: D000956:Antigens, Viral; C037662:EBV-associated membrane antigen, Epstein-Barr virus; D011518:Proto-Oncogene Proteins; D019253:Proto-Oncogene Proteins c-bcl-2; D014763:Viral Matrix Proteins